David Book, PharmD

During a presentation at the recent Community Oncology Alliance Annual Conference in Orlando, Florida, Ray Bailey, RPh, discussed the implications of medical marijuana for patients with cancer.

Lean, private firms being acquired by big pharma is not necessarily a new trend. But, with excitement in the health care technology space and established tech firms attempting to enter that market, partnerships are taking a new perspective to cut costs and increase quality.

This year, the technology giant highlighted 22 applications for patients. Here are the ones that are most relevant to pharmacists.

In 2016, novel medications approved by the FDA decreased from the encouraging tally of 45 that we saw last year to 22, the lowest it has been since 2010

As barriers to accessing medical cannabis continue to weaken across the country, more light is being shed on the potential benefits of other psychedelic substances.

What does President-elect Trump and a Republican-controlled Congress claim is in store for healthcare over the next four years?